Lithium carbonate
Lithobid, Lithonate (lithium carbonate) is a small molecule pharmaceutical. Lithium carbonate was first approved as Lithobid on 1982-01-01. It is used to treat bipolar disorder, conduct disorder, depressive disorder, and post-traumatic stress disorders in the USA.
Download report
Favorite
Searched
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
|---|---|
| mental disorders | D001523 |
Trade Name
FDA
EMA
Lithobid (generic drugs available since 1986-05-21, discontinued: Eskalith, Lithane, Lithonate, Lithotabs)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Lithium carbonate
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| lithium carbonate | ANDA | 2023-05-31 |
| lithobid | New Drug Application | 2020-02-07 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| bipolar disorder | EFO_0000289 | D001714 | F30.9 |
| conduct disorder | EFO_0004216 | D019955 | F91 |
| depressive disorder | EFO_1002014 | D003866 | F32.A |
| post-traumatic stress disorders | EFO_0001358 | D013313 | F43.1 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
203 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Bipolar disorder | D001714 | EFO_0000289 | F30.9 | 3 | 5 | 21 | 33 | 17 | 75 |
| Major depressive disorder | D003865 | EFO_0003761 | F22 | 3 | 3 | 3 | 7 | 4 | 18 |
| Depression | D003863 | F33.9 | 1 | 2 | 3 | 9 | 2 | 16 | |
| Depressive disorder | D003866 | EFO_1002014 | F32.A | — | 1 | 1 | 3 | 2 | 6 |
| Treatment-resistant depressive disorder | D061218 | — | 1 | 1 | 3 | 1 | 6 | ||
| Mania | D000087122 | F30 | — | — | 3 | 2 | 1 | 6 | |
| Cognitive dysfunction | D060825 | G31.84 | — | 1 | — | 2 | 1 | 4 | |
| Schizophrenia | D012559 | EFO_0000692 | F20 | — | — | 2 | 1 | — | 3 |
| Psychotic disorders | D011618 | F20.81 | — | 1 | — | 2 | — | 3 | |
| Dementia | D003704 | F03 | — | — | 1 | 1 | — | 2 |
Show 5 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Amyotrophic lateral sclerosis | D000690 | EFO_0000253 | G12.21 | — | 3 | 1 | — | — | 3 |
| Attempted suicide | D013406 | EFO_0004321 | T14.91 | — | 2 | 2 | — | — | 2 |
| Suicide | D013405 | — | 1 | 1 | — | 1 | 2 | ||
| Psychophysiologic disorders | D011602 | F45.9 | — | — | 1 | — | — | 1 | |
| Anxiety disorders | D001008 | EFO_0006788 | F41.1 | — | — | 1 | — | — | 1 |
| Autism spectrum disorder | D000067877 | F84.0 | — | — | 1 | — | — | 1 | |
| Alcoholism | D000437 | EFO_0003829 | F10.1 | — | — | 1 | — | — | 1 |
| Stroke | D020521 | EFO_0000712 | I63.9 | — | — | 1 | — | — | 1 |
| Machado-joseph disease | D017827 | EFO_0004135 | — | 1 | 1 | — | — | 1 | |
| Conduct disorder | D019955 | EFO_0004216 | F91 | — | — | 1 | — | — | 1 |
Show 5 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Spinal cord injuries | D013119 | EFO_1001919 | 4 | 5 | — | — | — | 6 | |
| Alzheimer disease | D000544 | EFO_0000249 | F03 | — | 3 | — | — | — | 3 |
| Covid-19 | D000086382 | U07.1 | — | 1 | — | — | 1 | 2 | |
| Small cell lung carcinoma | D055752 | 1 | 1 | — | — | 1 | 2 | ||
| Spinocerebellar ataxias | D020754 | 1 | 1 | — | — | — | 2 | ||
| Brain neoplasms | D001932 | EFO_0003833 | C71 | — | 1 | — | — | — | 1 |
| Progressive supranuclear palsy | D013494 | EFO_0002512 | G23.1 | 1 | 1 | — | — | — | 1 |
| Thyroid neoplasms | D013964 | EFO_0003841 | — | 1 | — | — | — | 1 | |
| Borderline personality disorder | D001883 | HP_0012076 | F60.3 | — | 1 | — | — | — | 1 |
| Dysthymic disorder | D019263 | EFO_0008623 | F34.1 | — | 1 | — | — | — | 1 |
Show 16 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Myeloid leukemia acute | D015470 | C92.0 | 1 | — | — | — | 1 | 2 | |
| Colorectal neoplasms | D015179 | 1 | — | — | — | — | 1 | ||
| Stomach neoplasms | D013274 | EFO_0003897 | C16 | 1 | — | — | — | — | 1 |
| Esophageal neoplasms | D004938 | C15 | 1 | — | — | — | — | 1 | |
| Megakaryoblastic leukemia acute | D007947 | C94.2 | 1 | — | — | — | — | 1 | |
| Monocytic leukemia acute | D007948 | 1 | — | — | — | — | 1 | ||
| Myelomonocytic leukemia acute | D015479 | C92.5 | 1 | — | — | — | — | 1 | |
| Erythroblastic leukemia acute | D004915 | EFO_1001257 | C94.0 | 1 | — | — | — | — | 1 |
| Parkinson disease | D010300 | EFO_0002508 | G20 | 1 | — | — | — | — | 1 |
| Type c niemann-pick disease | D052556 | Orphanet_646 | E75.242 | 1 | — | — | — | — | 1 |
Show 4 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Nonvital tooth | D019553 | — | — | — | — | 3 | 3 | ||
| Prosthesis failure | D011475 | — | — | — | — | 2 | 2 | ||
| Tooth wear | D057085 | — | — | — | — | 2 | 2 | ||
| Healthy volunteers/patients | — | — | — | — | — | 1 | 1 | ||
| Dental caries | D003731 | EFO_0003819 | K02 | — | — | — | — | 1 | 1 |
| Vitiligo | D014820 | EFO_0004208 | L80 | — | — | — | — | 1 | 1 |
| Tooth discoloration | D014075 | K03.6 | — | — | — | — | 1 | 1 | |
| Tooth loss | D016388 | — | — | — | — | 1 | 1 | ||
| Dental implants | D015921 | — | — | — | — | 1 | 1 | ||
| Sleep bruxism | D020186 | G47.63 | — | — | — | — | 1 | 1 |
Show 31 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | LITHIUM CARBONATE |
| INN | — |
| Description | Lithium carbonate is a lithium salt and a carbonate salt. It has a role as an antimanic drug. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | O=C([O-])[O-].[Li+].[Li+] |
Identifiers
| PDB | — |
| CAS-ID | 554-13-2 |
| RxCUI | 42351 |
| ChEMBL ID | CHEMBL1200826 |
| ChEBI ID | 6504 |
| PubChem CID | 11125 |
| DrugBank | DB14509 |
| UNII ID | — |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 130,833 documents
View more details
Safety
Black-box Warning
Black-box warning for: Lithium carbonate, Lithobid
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
14,226 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more